Cargando…

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) have recently been proposed, distinguishing this syndrome from other inflammatory diseases of the central nervous system. Seropositivity status for MOG-IgG autoantibodies is important for diagnosing M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Ani, Abdullah, Chen, John J., Costello, Fiona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Neurological Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165591/ https://www.ncbi.nlm.nih.gov/pubmed/37154894 http://dx.doi.org/10.1007/s00415-023-11737-8

Ejemplares similares

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
por: Sechi, Elia, et al.
Publicado: (2022)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challenge
por: Azar, Chadi, et al.
Publicado: (2023)

Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
por: Lotan, Itay, et al.
Publicado: (2023)

Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
por: Nakajima, Hideki, et al.
Publicado: (2015)

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
por: Perez-Giraldo, Gina, et al.
Publicado: (2023)

Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review
por: Molazadeh, Negar, et al.
Publicado: (2022)

General anesthesia, using remimazolam, for the patient with myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): A case report
por: Hong, Seung-Wan, et al.
Publicado: (2022)

Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease according to their epitopes
por: Seok, Jin Myoung, et al.
Publicado: (2023)

Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD)
por: Li, Yunjie, et al.
Publicado: (2022)

Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Relapse With COVID-19
por: Woodhall, Mark, et al.
Publicado: (2020)

Dimethyl Fumarate Was Ineffective but Not Harmful for a Patient with Myelin Oligodendrocyte Glycoprotein Antibody Disease
por: Warabi, Yoko, et al.
Publicado: (2019)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
por: Parrotta, Erica, et al.
Publicado: (2020)

Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide
por: Hor, Jyh Yung, et al.
Publicado: (2023)

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
por: Santoro, Jonathan D., et al.
Publicado: (2023)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series
por: Gadama, Yohane, et al.
Publicado: (2023)

Seizure and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis in a Retrospective Cohort of Chinese Patients
por: Zhong, Xiaonan, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
por: Zhang, Min, et al.
Publicado: (2020)

Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)
por: Hiya, Satomi, et al.
Publicado: (2023)

Myelin Oligodendrocyte Glycoprotein Optic Neuritis Presenting With Orbital Apex Syndrome
por: Sulaiman, Farhana Nabila, et al.
Publicado: (2023)

Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum
por: Alshamrani, Foziah, et al.
Publicado: (2020)

Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes
por: Simone, Marta, et al.
Publicado: (2021)

Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune Myelopathy
por: Alkabie, Samir, et al.
Publicado: (2022)

Unilateral Autoimmune Encephalitis: A Case Report on a Rare Manifestation of Myelin Oligodendrocyte Glycoprotein Antibody Disease
por: Maturu, Mohan V. Sumedha, et al.
Publicado: (2023)

A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective
por: Wang, Yufei, et al.
Publicado: (2023)

Phenotypic characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in children: a single-center, retrospective study
por: Hua, Yi, et al.
Publicado: (2023)

Contemporary management challenges in seropositive NMOSD
por: Costello, Fiona, et al.
Publicado: (2022)

Publisher Correction: Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
por: Santoro, Jonathan D., et al.
Publicado: (2023)

Bilateral Acute Optic Perineuritis Associated With COVID-19 in a Patient With Seronegative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Ali, Liaquat, et al.
Publicado: (2021)

Editorial: MOGAD, current knowledge and future trends
por: Siritho, Sasitorn, et al.
Publicado: (2023)

The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
por: Xu, Jie, et al.
Publicado: (2021)

Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum
por: Budhram, Adrian, et al.
Publicado: (2022)

Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
por: Lipps, Patrick, et al.
Publicado: (2023)

Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series
por: Lambe, Jeffrey, et al.
Publicado: (2022)

A Case of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis Responsive to Intravenous Immunoglobulin (IVIG) Therapy in a Pediatric Patient
por: Kadam, Rochita, et al.
Publicado: (2023)

Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Takano, Shunichiro, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
por: Mao, Leilei, et al.
Publicado: (2019)

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein-Associated Disorders Post-ChAdOx1 Vaccination
por: Maramattom, Boby Varkey
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1qo5igrqfem2n2hqkqlvtk095s